Peptide-Based Drugs in the Era of Antimicrobial Resistance

A special issue of Antibiotics (ISSN 2079-6382).

Deadline for manuscript submissions: closed (28 February 2026) | Viewed by 649

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Chemistry, National Autonomous University of Mexico (UNAM), Mexico City, Mexico
Interests: antimicrobial peptides; pore-forming proteins; biotoxins; protein engineering; transcriptomics; proteomics; bioassays; bionanotechnology

E-Mail Website
Guest Editor
Facultad de Ciencias Químicas, Universidad de Colima, Colima, Mexico
Interests: peptides; biodiversity; proteins; mass spectrometry; proteomics; peptide synthesis; protein purification; chromatography; protein mass spectrometry; protein identification; antimicrobial peptides

Special Issue Information

Dear Colleagues,

In the context of rising resistance to conventional antibiotics, antimicrobial peptides (AMPs) have emerged as therapeutic alternatives. Their broad-spectrum activity (targeting bacteria, fungi, viruses, and certain parasites), combined with their ability to modulate immune responses and their rapid, multifactorial mechanisms of action, positions them as promising tools in the fight against antimicrobial resistance (AMR). Moreover, their structural versatility and amenability to optimization through molecular engineering or rational design make them strong candidates for the development of next-generation therapeutics.

Despite their potential, several technical and biological challenges remain to be solved prior to clinical use. Key obstacles include their limited stability against proteolytic degradation, potential cytotoxicity toward human cells, and the need for effective delivery systems to ensure targeted and sustained activity in biological environments.

This Special Issue aims to gather recent research on antimicrobial peptides, covering their discovery, characterization, optimization, and therapeutic application. We welcome studies on the validation of novel peptides, structure–function analyses, biological evaluation, delivery platforms, and multidisciplinary approaches that integrate biotechnology, bioinformatics, medicinal chemistry, and nanotechnology in the context of antimicrobial resistance.

Dr. Santos Ramírez Carreto
Prof. Dr. Juana María Jiménez-Vargas
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antimicrobial resistance
  • antimicrobial activity
  • novel antimicrobial peptides
  • structure–activity relationship
  • bionanotechnology
  • improvement of biological stability
  • rational drug design
  • optimization of drug delivery systems

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 3150 KB  
Article
Short Synthetic Lipopeptides C16-KK-NH2 and (C10)2-KKKK-NH2 Enhance the Activities of Erythromycin and Tetracycline Against ESKAPE Pathogens
by Malgorzata Anna Paduszynska, Alena Shchuka and Katarzyna Ewa Greber
Antibiotics 2026, 15(5), 439; https://doi.org/10.3390/antibiotics15050439 - 28 Apr 2026
Viewed by 311
Abstract
Background: ESKAPE constitutes a group of six nosocomial bacteria that can evade available antimicrobials due to their great potential to develop multi-drug resistance and biofilm-forming abilities. These pathogens often cause hospital-acquired infections and pose a serious threat to public health. The search for [...] Read more.
Background: ESKAPE constitutes a group of six nosocomial bacteria that can evade available antimicrobials due to their great potential to develop multi-drug resistance and biofilm-forming abilities. These pathogens often cause hospital-acquired infections and pose a serious threat to public health. The search for efficient innovative therapeutic strategies to fight ESKAPE bacteria have been intensively investigated topics. One promising approach to fight resistant pathogens and their biofilms is combination therapy, which allows the effectiveness against microorganisms to be increased while reducing the applied concentrations and risks of potential unwanted side effects. Objectives: The object of the study was to determine if there is an interaction of short lipopeptides ((C10)2-KKKK-NH2, C16-KK-NH2) together with erythromycin and tetracycline against pathogens of the ESKAPE group (Acinetobacter baumannii, Enterobacter aerogenes, Enterococcus faecium Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus). Methods: The checkerboard assay was used to examine the activity of compounds applied in combinations against ESKAPE strains in planktonic cells and toward biofilms formed by Staphylococcus aures and Pseudomonas aeruginosa. Results: The lipopeptides demonstrated a great potential of their application as additives to conventional antimicrobials against Gram-negative bacteria, including microorganisms within biofilms. Full article
(This article belongs to the Special Issue Peptide-Based Drugs in the Era of Antimicrobial Resistance)
Show Figures

Figure 1

Back to TopTop